High Content Screening Market - Forecasts to 2018

MarketsandMarkets Presents

High Content Screening Market worth $615.8 Million by 2018 http://www.marketsandmarkets.com/Market-Reports/high-content-screening-market42710391.html

The “High Content Screening Market by Instruments (Cell Imaging and Analysis System)

by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018” analyzes and studies the major market drivers, restraints, andopportunities in North America, Europe, Asia, and the Rest of the World (RoW).

Browse more than 50 market data tables with 10 figures spread through 151 pages and in-depth TOC on "High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018“

http://www.marketsandmarkets.com/Market-Reports/high-content-screening-market42710391.html Early buyers will receive 10% customization on reports.

http://www.marketsandmarkets.com/Market-Reports/high-content-screening-market42710391.html

In recent years, the adoption of high content screening in various phases of drug discovery has increased. The global was valued at $362.2 million in 2013 and is expected to reach $615.8 million by 2018, at a CAGR of 11.2%. The market is broadly classified based on products, applications, end users, and geographies.

The product market is further divided into instruments, consumables, software, and services. The instruments market is sub-divided into cell imaging and analysis systems and flow cytometers. The consumables market is further segmented into reagents and assay kits, microplates, and other consumables. The software market includes the market for image analysis and data management software. The services market includes screeningservices such as primary screening and secondary screening, services related to target identification and validation, toxicity studies, and compound profiling.

Buy Now: http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=42710391

http://www.marketsandmarkets.com/Market-Reports/high-content-screening-market42710391.html

The applications market includes primary screening and secondary screening, target identification and validation, toxicity studies, compound profiling and other applications.

High content screening can be applied in both primary and secondary screening, although it is extensively used for the secondary screening process. In target identification, HCS is used to identify novel targets through the screening of cellular pathways. The other application of HCS is in studying cell signaling pathways. The primary and secondary screening market dominated the high content screening applications market, with a market share of 50% in 2013.

Free sample PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=42710391 The major factors driving the growth of the market include the need for determining the level of toxicity in the early stages of drug discovery pipeline, government support for cellbased research, and the introduction of enhanced informatics solutions and improved image analysis instruments. Moreover, the adoption of HCS for primary screening and its application in the development of personalized medicine are key growth opportunities in this market.

http://www.marketsandmarkets.com/Market-Reports/high-content-screening-market42710391.html

However, the high cost of the high content screening systems may hinder the growth of this market. In addition, the shortage of knowledgeable and skilled professionals for high content screening remains a major challenge for this market.

The global market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America will continue to lead the global market in the forecast period, followed by Europe. Over the next five years, the growth of the global market in the Asian region is likely to be centered on China, Japan, Singapore, and India. This growth will be driven by government support for the growth of innovative technologies and the rising demand for outsourcing of drug discovery services.

The major players in the market include Thermo Fisher Scientific (U.S.), Molecular Devices (acquired by Danaher Corporation) (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Cell Signaling Technology (U.S.), Genedata AG (Switzerland), Merck KGaA (Germany), Thorlabs, Inc. (U.S.), and Yokogawa Electric Corporation (Japan), among others

http://www.marketsandmarkets.com/Market-Reports/high-content-screening-market42710391.html

About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

http://www.marketsandmarkets.com/Market-Reports/high-content-screening-market42710391.html

Contact Us Mr. Rohan North - Dominion Plaza, 17304 Preston Road, Suite 800, Dallas, TX 75252 Tel: +1-888-6006-441 Email: sales@marketsandmarkets.com MarketsandMarkets Blog http://www.marketsandmarkets.com http://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets